Han Zhong Li
Directeur/Membre du Conseil chez AIMFINITY INVESTMENT CORP. I
Profil
Han Zhong Li is an Independent Non-Executive Director at YishengBio Co., Ltd.
and an Independent Director at Aimfinity Investment Corp.
I.
He is also an Independent Director at Inkstone Feibo Acquisition Corp.
and the Senior Vice President-Development at Eureka Therapeutics, Inc. Dr. Li previously worked as a Director & Senior Vice President at Truist Securities, Inc., Deputy Director-Strategy & Portfolio Management at Bayer Pharmaceuticals Corp., and Senior Vice President at Stanford Financial Group Ltd.
(Texas).
He was also the Chief Financial Officer at Ascentage Pharma Group International Co., Ltd.
Dr. Li received his undergraduate degree from Washington State University, his MBA from UCLA Anderson School of Management, and his doctorate from Boston University School of Medicine.
Postes actifs de Han Zhong Li
| Sociétés | Poste | Début |
|---|---|---|
| AIMFINITY INVESTMENT CORP. I | Directeur/Membre du Conseil | 17/03/2023 |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Directeur/Membre du Conseil | - |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2019 |
Inkstone Feibo Acquisition Corp.
 Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | Directeur/Membre du Conseil | - |
Anciens postes connus de Han Zhong Li
| Sociétés | Poste | Fin |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Directeur Financier/CFO | 01/12/2018 |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | 01/07/2017 |
Stanford Financial Group Ltd. (Texas)
 Stanford Financial Group Ltd. (Texas) Investment Banks/BrokersFinance Stanford Financial Group Ltd provides financial advisory services. The company is based in Houston, Texas. | Corporate Officer/Principal | 01/10/2009 |
Truist Securities, Inc.
 Truist Securities, Inc. Investment Banks/BrokersFinance Truist Securities, Inc. is a registered broker-dealer headquartered in Atlanta, Georgia. The firm was founded in 1894 as SunTrust Robinson Humphrey, Inc. In 2020, the firm was renamed following the integration of SunTrust Robinson Humphrey and BB&T Capital Markets. The firm is a subsidiary of Truist Financial Corp. (NYSE: TFC) and is an active market maker in equity and fixed-income products. Truist Securities delivers a comprehensive range of strategic advisory, capital raising, risk management, and financing solutions, as well as a dynamic suite of sales, trading, and research services in both fixed-income and equity. Their strategies are carefully tailored to meet the needs and vision of their clients. | Directeur/Membre du Conseil | 01/06/2006 |
Formation de Han Zhong Li
| Washington State University | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
| Boston University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
| AIMFINITY INVESTMENT CORP. I | Finance |
| Entreprise privées | 6 |
|---|---|
Truist Securities, Inc.
Truist Securities, Inc. Investment Banks/BrokersFinance Truist Securities, Inc. is a registered broker-dealer headquartered in Atlanta, Georgia. The firm was founded in 1894 as SunTrust Robinson Humphrey, Inc. In 2020, the firm was renamed following the integration of SunTrust Robinson Humphrey and BB&T Capital Markets. The firm is a subsidiary of Truist Financial Corp. (NYSE: TFC) and is an active market maker in equity and fixed-income products. Truist Securities delivers a comprehensive range of strategic advisory, capital raising, risk management, and financing solutions, as well as a dynamic suite of sales, trading, and research services in both fixed-income and equity. Their strategies are carefully tailored to meet the needs and vision of their clients. | Finance |
| Bayer Pharmaceuticals Corp. | |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Health Technology |
Stanford Financial Group Ltd. (Texas)
Stanford Financial Group Ltd. (Texas) Investment Banks/BrokersFinance Stanford Financial Group Ltd provides financial advisory services. The company is based in Houston, Texas. | Finance |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |
Inkstone Feibo Acquisition Corp.
Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | Finance |
